Hersey Christine Ann 4

What Happened
Christine Ann Hersey, Trulieve Cannabis Corp.'s Chief of Corporate Affairs & Strategy, was granted compensation awards on March 13, 2026: 58,594 restricted stock units (RSUs) and 41,668 derivative awards (an option-like award). Both grants show an acquisition price of $0.00 (i.e., awards issued as compensation rather than purchased). These are grants, not open-market buys or sales.

Key Details

• Transaction date: 2026-03-13; Form 4 filed 2026-03-17 (filed within the SEC two-business-day window).
• Award amounts: 58,594 RSUs (non-derivative) and 41,668 derivative awards (option-type). Reported price: $0.00 (grant).
• Vesting/terms: RSUs vest 50% on Dec 1, 2027 and 50% on Dec 1, 2028 (Footnote F1). The derivative award becomes exercisable in three annual installments: 1/3 on Dec 1, 2026; 1/3 on Dec 1, 2027; and 1/3 on Dec 1, 2028 (Footnote F2).
• Shares owned after the transaction: not disclosed in the provided filing excerpt.
• Transaction code: A = Award/Grant. No tax withholding or cashless sale noted in the excerpt.

Context
RSUs are contingent rights that convert to shares only if/when they vest; derivative awards/options give a future right to acquire shares once exercisable. Grants like these are typical executive compensation and do not, by themselves, indicate a purchase-based bullish signal or immediate sale — they represent potential future share issuance subject to vesting and exercise rules.